SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-019341
Filing Date
2016-05-05
Accepted
2016-05-05 21:38:53
Documents
2
Period of Report
2016-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3784
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4500
  Complete submission text file 0000899243-16-019341.txt   9684
Mailing Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757
Business Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757 508-473-5993
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. 113 CEDAR STREET, STE S-7 MILFORD MA 01757
Business Address
Bates Jonathan (Reporting) CIK: 0001665265 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37718 | Film No.: 161625751